Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 13:13:100706.
doi: 10.1016/j.bonr.2020.100706. eCollection 2020 Dec.

A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration

Ethem Turgay Cerit  1 , Mahinur Cerit  2
Affiliations
Case Reports

A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration

Ethem Turgay Cerit et al. Bone Rep. .

Abstract

Background: Pregnancy and lactation associated osteoporosis (PLO) is a rare condition that may present with fragility fractures occurring for the first time in pregnancy or postpartum period while breastfeeding. Here, we report a rare case of PLO in the 3rd pregnancy treated with teriparatide.

Case report: A 35-year-old woman who presented with back pain (visual analogue scale; VAS = 10/10) two months after her third delivery. PLO was diagnosed from multiple vertebral fragility fractures and low bone mineral density (BMD). She was treated with teriparatide and her pain significantly reduced in the second month. After 12 months of teriparatide treatment, her BMD increased 18.1% from the baseline.

Conclusion: PLO should be considered in patients who complain with back pain during late pregnancy and postpartum period. Weaning off breastfeeding and supplementation of calcium/vitamin D should be the first recommendation as conventional treatment after the diagnosis of PLO. Teriparatide may be an effective option to improve the recovery of BMD If there is not enough improvement with conventional treatment.

Keywords: Lactation; Osteoporosis; Parathyroid hormone related peptide; Pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors solemnly declare that there is not any conflict of interest in this manuscript.

Figures

Fig. 1
Fig. 1
Sagittal T1 magnetic resonance images of the thoracic and lumbar spine shows acute bone marrow edema at T11 vertebra and loss of height at T5–7, 9 and L1 vertebrae (height loss ratios at T5, T6, T7, T9 and L1 are 24%, 25%, 23%, 24%, 27% respectively).
See this image and copyright information in PMC

References

    1. Adamidou L.K., Trovas G., Stathopoulos I.P., Papaioannou N.A. Case report: teriparatide treatment in a case of severe pregnancy -and lactation-associated osteoporosis. Hormones (Athens). 2012 Oct-Dec;11(4):495–500. - PubMed
    1. Black A.J., Topping J., Durham B., Farquharson R.G. Fraser WD.A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J. Bone Miner. Res. 2000 Mar;15(3):557–563. - PubMed
    1. Choe E.Y., Song J.E., Park K.H., Seok H., Lee E.J., Lim S.K. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J. Bone Miner. Metab. 2012 Sep;30(5):596–601. - PubMed
    1. Gambacciani M., Spinetti A., Gallo R., Cappagli B., Teti G.C., Facchini V. Ultrasonographic bone characteristics during normal pregnancy: longitudinal and cross-sectional evaluation. Am. J. Obstet. Gynecol. 1995 Sep;173(3 Pt 1):890–893. - PubMed
    1. Hadji P., Boekhoff J., Hahn M., Hellmeyer L., Hars O., Kyvernitakis I. Pregnancy-associated osteoporosis: a case-control study. Osteoporos. Int. 2017 Apr;28(4):1393–1399. - PubMed

Publication types

LinkOut - more resources